284 related articles for article (PubMed ID: 29402662)
21. Using an Electronic Medication Refill System to Improve Provider Productivity in an Accountable Care Setting.
Schoenhaus R; Lustig A; Rivas S; Monrreal V; Westrich KD; Dubois RW
J Manag Care Spec Pharm; 2016 Mar; 22(3):204-8. PubMed ID: 27003549
[TBL] [Abstract][Full Text] [Related]
22. Short-acting β-agonist use and its ability to predict future asthma-related outcomes.
Stanford RH; Shah MB; D'Souza AO; Dhamane AD; Schatz M
Ann Allergy Asthma Immunol; 2012 Dec; 109(6):403-7. PubMed ID: 23176877
[TBL] [Abstract][Full Text] [Related]
23. Seasonal patterns of controller and rescue medication dispensed in underserved children with asthma.
Butz AM; Thompson RE; Tsoukleris MG; Donithan M; Hsu VD; Mudd K; Zuckerman IH; Bollinger ME
J Asthma; 2008 Nov; 45(9):800-6. PubMed ID: 18972299
[TBL] [Abstract][Full Text] [Related]
24. Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbations.
Paris J; Peterson EL; Wells K; Pladevall M; Burchard EG; Choudhry S; Lanfear DE; Williams LK
Ann Allergy Asthma Immunol; 2008 Nov; 101(5):482-7. PubMed ID: 19055201
[TBL] [Abstract][Full Text] [Related]
25. Overprescription of short-acting β
Al Zaabi A; Busaidi N; Al Mutairy S; Yorgancıoğlu A; Aksu K; Al-Jahdali H; Wali S; Elsayed M; Beekman MJ
Expert Rev Respir Med; 2022 Jul; 16(7):833-847. PubMed ID: 35848074
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of Population Health Management Using the Propeller Health Asthma Platform: A Randomized Clinical Trial.
Merchant RK; Inamdar R; Quade RC
J Allergy Clin Immunol Pract; 2016; 4(3):455-63. PubMed ID: 26778246
[TBL] [Abstract][Full Text] [Related]
27. Real-time asthma outreach reduces excessive short-acting β2-agonist use: a randomized study.
Zeiger RS; Schatz M; Li Q; Solari PG; Zazzali JL; Chen W
J Allergy Clin Immunol Pract; 2014; 2(4):445-456, 456.e1-5. PubMed ID: 25017534
[TBL] [Abstract][Full Text] [Related]
28. Pharmacy-specific quality indicators for asthma therapy.
Winterstein AG; Hartzema AG
Res Social Adm Pharm; 2005 Sep; 1(3):430-45. PubMed ID: 17138488
[TBL] [Abstract][Full Text] [Related]
29. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
Chan J; Hui RL; Spence MM
J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
[TBL] [Abstract][Full Text] [Related]
30. Electronic medical record reduces HIV medication refill response time and emergency refills in a Latino community clinic.
Pearce DD; Opperman JM
Int J STD AIDS; 2010 Mar; 21(3):184-6. PubMed ID: 20215622
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the Feasibility of a Community Pharmacy-Delivered Behaviour Change Intervention to Reduce Reliever Reliance in Asthma.
Foot H; Beyene K; Horne R; Fingleton J; Harrison J; Chan AHY
Patient Prefer Adherence; 2024; 18():361-371. PubMed ID: 38344153
[TBL] [Abstract][Full Text] [Related]
32. Impact of a pharmacist-driven intervention on the outpatient dispensing of naloxone.
Griffin S; Wishart B; Bricker K; Luebchow A
J Am Pharm Assoc (2003); 2019; 59(4S):S161-S166. PubMed ID: 31326040
[TBL] [Abstract][Full Text] [Related]
33. Impact of an ambulatory care pharmacist in an occupational health clinic.
Parsons KA; Zimmermann AE
J Am Pharm Assoc (2003); 2019; 59(1):64-69.e1. PubMed ID: 30396761
[TBL] [Abstract][Full Text] [Related]
34. The Iowa new practice model: Advancing technician roles to increase pharmacists' time to provide patient care services.
Andreski M; Myers M; Gainer K; Pudlo A
J Am Pharm Assoc (2003); 2018; 58(3):268-274.e1. PubMed ID: 29606624
[TBL] [Abstract][Full Text] [Related]
35. Understanding reliever overuse in patients purchasing over-the-counter short-acting beta
Azzi EA; Kritikos V; Peters MJ; Price DB; Srour P; Cvetkovski B; Bosnic-Anticevich S
BMJ Open; 2019 Aug; 9(8):e028995. PubMed ID: 31412998
[TBL] [Abstract][Full Text] [Related]
36. Short-acting beta-agonist prescription fills as a marker for asthma morbidity.
Naureckas ET; Dukic V; Bao X; Rathouz P
Chest; 2005 Aug; 128(2):602-8. PubMed ID: 16100144
[TBL] [Abstract][Full Text] [Related]
37. Development of a pharmacist-provided contraceptive service following passage of Oregon House Bill 2879.
Walsh S; Irwin AN; Anderson L; Zehrung C
J Am Pharm Assoc (2003); 2019; 59(4S):S112-S116. PubMed ID: 31010785
[TBL] [Abstract][Full Text] [Related]
38. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
39. Telephoning the patient's pharmacy to assess adherence with asthma medications by measuring refill rate for prescriptions.
Sherman J; Hutson A; Baumstein S; Hendeles L
J Pediatr; 2000 Apr; 136(4):532-6. PubMed ID: 10753254
[TBL] [Abstract][Full Text] [Related]
40. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
Griffiths B; Ducharme FM
Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
